<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS199808</article-id><article-id pub-id-type="doi">10.1101/2024.10.29.620545</article-id><article-id pub-id-type="archive">PPR933397</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Sequential transcriptional programs underpin activation of quiescent hippocampal stem cells</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Rigo</surname><given-names>Piero</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ahmed-de-Prado</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Johnston</surname><given-names>Rebecca L.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Choudhury</surname><given-names>Chandra</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Guillemot</surname><given-names>François</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Harris</surname><given-names>Lachlan</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="fn" rid="FN1">6</xref><xref ref-type="fn" rid="FN2">7</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Neural Stem Cell Biology Laboratory, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tnbqb63</institution-id><institution>The Francis Crick Institute</institution></institution-wrap>, <city>London</city><postal-code>NW1 1AT</postal-code>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/004y8wk30</institution-id><institution>QIMR Berghofer Medical Research Institute</institution></institution-wrap>, <city>Brisbane</city>, <state>QLD</state>, <postal-code>4006</postal-code>, <country country="AU">Australia</country></aff><aff id="A3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rqy9422</institution-id><institution>The University of Queensland</institution></institution-wrap>, <state>QLD</state>, <postal-code>4067</postal-code>, <country country="AU">Australia</country></aff><aff id="A4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03pnv4752</institution-id><institution>Queensland University of Technology</institution></institution-wrap>, <state>QLD</state>, <postal-code>4059</postal-code>, <country country="AU">Australia</country></aff><author-notes><fn fn-type="present-address" id="FN1"><label>6</label><p id="P1">Work partially conducted at <sup>1</sup>, current address <sup>2</sup></p></fn><fn id="FN2"><label>7</label><p id="P2">lead contact:</p></fn><corresp id="CR1"><label>*</label>corresponding author: <email>Lachlan.harris@qimrberghofer.edu.au</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>02</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>31</day><month>10</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P3">Postnatal neural stem cells are primarily quiescent, which is a cellular state that exists as a continuum from deep to shallow quiescence. The molecular changes that occur along this continuum are beginning to be understood but the transcription factor network governing these changes has not been defined. We show that these transitions are regulated by sequential transcription factor programs. Single-cell transcriptomic analyses of mice with loss- or gain-of-function of the essential activation factor <italic>Ascl1</italic>, reveal that Ascl1 promotes the activation of hippocampal neural stem cells by driving these cells out of deep quiescence, despite its low protein expression. Subsequently, during the transition from deep to shallow quiescence, <italic>Ascl1</italic> induces the expression of <italic>Mycn</italic>, which drives progression through shallow states of quiescence towards an active state. Together, these results define the required sequence of transcription factors during hippocampal neural stem cell activation.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P4">Cellular quiescence is not a single state but a spectrum. Stem cells that are in shallow quiescence, for example in a G<sub>alert</sub> state, have short activation times, whereas deeply quiescent cells require prolonged growth factor signalling to activate<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. The different states of quiescence have functional significance. For example, tissue injury pushes muscle stem cells and haemotopioetic stem cells in uninjured areas of the body into a shallow quiescent state, thereby priming these cells for regenerative activity<sup><xref ref-type="bibr" rid="R2">2</xref></sup>. In contrast, fasting pushes muscle stem cells into deep quiescence, decreasing regenerative capacity but increasing the resilience of the cells to stress<sup><xref ref-type="bibr" rid="R3">3</xref></sup>.</p><p id="P5">Likewise, in the central nervous system, quiescent neural stem cells (NSCs) exhibit different depths of quiescence. Injury pushes quiescent NSCs in the subventricular zone into a ‘primed’ state of shallow quiescence<sup><xref ref-type="bibr" rid="R4">4</xref></sup>. NSCs that return to quiescence from a proliferating state enter a shallow ‘resting’ state of quiescence, which increases the probability that these cells will re-enter the cell-cycle in the short term compared to cells that have not divided recently<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref></sup>. Finally, NSCs also progress into deeper states of quiescence the longer they remain quiescent, which reduces the activation rate of NSCs in aging animals<sup><xref ref-type="bibr" rid="R6">6</xref>–<xref ref-type="bibr" rid="R8">8</xref></sup>.</p><p id="P6">Despite the functional significance of these different states, how adult NSCs convert between states of deep and shallow quiescence is poorly defined. Here, we reveal that in adult mouse NSCs, activation from deep quiescence and shallow quiescence is governed by distinct and sequential molecular programs. Progression from deep quiescence to shallow quiescence is promoted by the <italic>Ascl1</italic> transcription factor. ASCL1 induces the expression of <italic>Mycn</italic> to push cells through shallow states of quiescence into an active state. These defined transitions may explain how populations of hippocampal NSCs are maintained in distinct states of quiescence.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Ascl1 deletion impairs progression from deep states of quiescence</title><p id="P7">Expression of the transcription factor ASCL1 is essential for the activation of adult hippocampal NSCs<sup><xref ref-type="bibr" rid="R9">9</xref></sup>. ASCL1 must also be degraded for active NSCs to return to a quiescent state<sup><xref ref-type="bibr" rid="R10">10</xref></sup>. While analysis of ASCL1 function has focused so far on its role in the active NSCs, there is clear evidence that ASCL1 is also expressed in quiescent NSCs, albeit at lower levels, raising the possibility that it has a role in this population<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R11">11</xref></sup>. To determine how ASCL1 might function during quiescence, we performed single-cell RNA-sequencing (scRNA-seq) of hippocampal NSCs after acute deletion of the <italic>Ascl1</italic> gene.</p><p id="P8">We administered tamoxifen to Ascl1<italic>fl/fl</italic>; Glast-creERT2; Rosa-YFP mice (<italic>Ascl1</italic> cKO) at 1-month of age, deleting the <italic>Ascl1</italic> gene from NSCs and parenchymal astrocytes, while irreversibly labelling recombined cells with yellow fluorescent protein (YFP)<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>. Twelve-days after tamoxifen administration, we disassociated the dentate gyrus of <italic>Ascl1</italic> cKO mice, as well as control animals that lacked the conditional <italic>Ascl1</italic> allele. We sorted the recombined YFP+ <italic>Ascl1</italic> cKO and control cells by flow cytometry and performed scRNA-seq with the 10x Genomics platform (<xref ref-type="fig" rid="F1">Figure 1A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). In total, 12,548 cells from <italic>Ascl1</italic> cKO mice and 9,189 cells from controls, across three independent experiments passed quality control. We first inspected our data by isolating the three main neurogenic cell clusters (<xref ref-type="fig" rid="F1">Figure 1B</xref>). These clusters comprised quiescent NSCs, proliferating cells (both active NSCs and intermediate progenitor cells, which cluster together due to dominance of cell-cycle gene expression) and neuroblasts, which we demarcated according to the expression of canonical markers <italic>Hopx<sup><xref ref-type="bibr" rid="R14">14</xref></sup></italic>, <italic>Eomes/MKi67</italic> and <italic>Dcx<sup><xref ref-type="bibr" rid="R15">15</xref></sup></italic> respectively, as previously described<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Consistent with the established role for ASCL1 in active NSCs<sup><xref ref-type="bibr" rid="R9">9</xref></sup>, loss of ASCL1 led to an almost complete absence of actively dividing cells in <italic>Ascl1</italic> cKO mice (<xref ref-type="fig" rid="F1">Figure 1C</xref>). In our scRNA-seq data of <italic>Ascl1</italic> cKO mice, only 8 cells were actively proliferating (0.55%) compared to 20% of control cells (<xref ref-type="fig" rid="F1">Figure 1D</xref>). We have previously reported that this block in proliferation leads to an accumulation of NSCs in a quiescent state because of a lack of division-coupled depletion<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R16">16</xref></sup>. Indeed, in our scRNA-seq data 96.2% of cells were quiescent NSCs compared to 25.3% of control cells (<xref ref-type="fig" rid="F1">Figure 1D</xref>). Finally, the block in proliferation also leads to a histological loss of immature neuronal progeny<sup><xref ref-type="bibr" rid="R9">9</xref></sup> and in our scRNA-seq data just 3.27% of cells in <italic>Ascl1</italic> cKO mice were neuroblasts compared to 54.8% of controls cells (<xref ref-type="fig" rid="F1">Figure 1D</xref>). The small number of aberrant proliferating cells and neuroblasts in our scRNA-seq data from <italic>Ascl1</italic> cKO mice was likely due to the incomplete recombination events<sup><xref ref-type="bibr" rid="R9">9</xref></sup>, as we detected <italic>Ascl1</italic> mRNA expression in the majority of remaining proliferating cells in the <italic>Ascl1</italic> cKO dataset. Our scRNA-seq data therefore faithfully recapitulates the histological phenotype of <italic>Ascl1</italic> cKO animals<sup><xref ref-type="bibr" rid="R9">9</xref></sup>, allowing us to use this sequencing tool to determine how <italic>Ascl1</italic> loss affects the underlying biology of the quiescent NSC population.</p><p id="P9">To examine the effect of <italic>Ascl1</italic> deletion on the quiescent stem cell population, we re-clustered the scRNA-seq data to only include NSCs (<italic>Hopx</italic>-high; <italic>S100b</italic>-low) (<xref ref-type="fig" rid="F1">Figure 1E</xref>) and then only quiescent NSCs, by removing proliferating cells (<xref ref-type="fig" rid="F1">Figure 1F</xref>). We arranged the quiescent NSCs along a pseudotime axis from deep to shallow quiescence using the trajectory inference tool Slingshot<sup><xref ref-type="bibr" rid="R17">17</xref></sup> (<xref ref-type="fig" rid="F1">Figure 1F</xref>). Loss of ASCL1 led to a pronounced phenotype in quiescent NSCs, where much of the NSC population shifted to extremely deep states of quiescence. Specifically, almost all quiescent NSCs from <italic>Ascl1</italic> cKO mice occupied the deepest 50% of pseudotime positions from control mice (<xref ref-type="fig" rid="F1">Figure 1F</xref>). These data demonstrate that loss of ASCL1 in adult NSCs causes profound transcriptional changes to all NSCs, including quiescent NSCs where it is expressed at low levels, ultimately moving the population into a deeper quiescent state. We next tested whether, conversely, increasing the level of ASCL1 protein might shift deeply quiescent NSCs to a shallow state.</p></sec><sec id="S4"><title>Ascl1 gain-of-function promotes progression from deep states of quiescence</title><p id="P10">To perform an ASCL1 gain-of-function analysis, we repeated the scRNA-seq experimental design, except this time deleting the gene encoding the ubiquitin-ligase HUWE1 (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The protein HUWE1 marks ASCL1 for proteasomal degradation. Our previous work has demonstrated that ASCL1 is the major substrate of HUWE1 in adult hippocampal NSCs and thus its deletion leads to elevated levels of ASCL1 protein in active NSCs<sup><xref ref-type="bibr" rid="R10">10</xref></sup> and in quiescent NSCs<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. The scRNA-seq analysis of dentate gyrus cells isolated from two independent experiments of <italic>Huwe1</italic> cKO mice (6,784 cells) and controls (5,187 cells) recapitulated our previous immunolabeling characterisation of this strain<sup><xref ref-type="bibr" rid="R10">10</xref></sup>. Specifically, a much larger percentage of cells from the neurogenic lineage were proliferating in <italic>Huwe1</italic> cKO mice (44.5% of cells) compared to control cells (13.6% of cells) (<italic>P</italic> = 0.08; <xref ref-type="fig" rid="F2">Figure 2B-D</xref>). Furthermore, as we have previously shown, <italic>Huwe1</italic> cKO neuroblasts fail to exit the cell-cycle and differentiate, resulting in apoptosis. This phenotype was manifested in the scRNA-seq analysis as a reduction in the proportion of neuroblasts (<italic>P</italic> = 0.08; <xref ref-type="fig" rid="F2">Figure 2B-D</xref>). We then re-clustered the scRNA-seq data to only include NSCs (<xref ref-type="fig" rid="F2">Figure 2E</xref>) and then only quiescent cells (<xref ref-type="fig" rid="F2">Figure 2F</xref>) and organised them into a pseudotime trajectory. We found that the increase in proliferation in <italic>Huwe1</italic> cKO mice was due to a marked shift in the stem cell population so that more mutant cells fell within the shallow end of the quiescence-to-activity trajectory and were likewise depleted from deep states of quiescence (<xref ref-type="fig" rid="F2">Figure 2F</xref>). Together, the pseudotime trajectories of <italic>Ascl1</italic> loss- and gain-of-function mice reveal a surprisingly early role for ASCL1 in the activation process. Despite the low levels of ASCL1 protein in deeply quiescent NSCs, ASCL1 is required to promote the progression of these cells from deep to shallow quiescence. These results help to explain our previous observations that NSCs progress into deeper states of quiescence during aging and that this was tightly correlated with decreasing ASCL1 protein levels in quiescent hippocampal NSCs in older mice<sup><xref ref-type="bibr" rid="R6">6</xref></sup>.</p></sec><sec id="S5"><title>MYCN promotes progression from shallow states of quiescence</title><p id="P11">We next wondered whether the subsequent progression of adult NSCs through shallow quiescence and into an active state might be associated with the activity of transcription factor(s) other than ASCL1. NSCs in shallow quiescence such as primed and resting cells have higher expression of genes associated with mRNA transport and protein translation<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R18">18</xref></sup>. These pathways have been shown to be upregulated by <italic>Myc</italic> transcription factors in other quiescence-associated contexts, such as during diapause in preimplantation embryos and in dormant haemopoietic stem cells<sup><xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R20">20</xref></sup>. This led us to hypothesise that the <italic>Myc</italic> gene family might similarly increase the expression of these pathways in quiescent NSCs to promote the activation of these cells out of shallow quiescence.</p><p id="P12">We first individually deleted the three <italic>Myc</italic> gene family members from adult stem cells and parenchymal astrocytes, by crossing conditional <italic>Myc<sup><xref ref-type="bibr" rid="R21">21</xref></sup></italic>, <italic>Mycn<sup><xref ref-type="bibr" rid="R22">22</xref></sup></italic> and <italic>Mycl</italic> mice<sup><xref ref-type="bibr" rid="R23">23</xref></sup> to <italic>Glast-creERT2</italic> animals. For each strain, we administered tamoxifen to 2-month-old animals, culling them 30-days later (<xref ref-type="supplementary-material" rid="SD5">Figure S1</xref>). Potential genetic redundancy between <italic>Myc</italic> family members was explored by generating a triple cKO strain (<xref ref-type="supplementary-material" rid="SD5">Figure S2</xref>)<sup><xref ref-type="bibr" rid="R24">24</xref></sup>. We stained brain slices for the immature neuronal marker DCX, as a preliminary screen for underlying defects in NSC activation, which, all else being equal, would be expected to culminate in reduced levels of adult neurogenesis. Of the three family members, <italic>Mycn</italic> had the highest mRNA expression in cells of the neurogenic lineage (<xref ref-type="supplementary-material" rid="SD5">Figure S1</xref>). Consistent with this, deletion of <italic>Mycn</italic> from adult NSCs, though not that of <italic>Myc</italic> or <italic>Mycl</italic>, led to a substantial reduction in DCX-positive cells compared to control mice (<xref ref-type="supplementary-material" rid="SD5">Figure S1</xref>). Conditional deletion of all three <italic>Myc</italic> genes did not exacerbate the phenotype beyond that of the single <italic>Mycn</italic> gene deletion (<xref ref-type="supplementary-material" rid="SD5">Figure S2</xref>). Therefore, <italic>Mycn</italic>, but not the other <italic>Myc</italic> genes, has an important role in promoting adult neurogenesis in the mouse hippocampus.</p><p id="P13">We next examined whether the phenotype of <italic>Mycn</italic> cKO was brought about by an underlying impairment in the NSC activation process. The expression of MYCN protein supported a possible role in regulating NSC activation, with 20% of quiescent NSCs (radial GFAP+SOX2+cells) expressing the protein in <italic>Mycn</italic> control mice at 6-weeks of age (<xref ref-type="supplementary-material" rid="SD5">Figure S3A, B</xref>), which largely reflected the mRNA expression in a subset of NSCs in shallow quiescence (<xref ref-type="supplementary-material" rid="SD5">Fig S1G</xref>). Quantification of NSCs revealed that deletion of <italic>Mycn</italic> reduced the proportion of adult hippocampal NSCs that were proliferating by 80% (<xref ref-type="supplementary-material" rid="SD5">Figure S3C, D</xref>) but did not affect overall NSC number (<xref ref-type="supplementary-material" rid="SD5">Figure S3E</xref>). To define how Mycn loss leads to decreased proportion of proliferating hippocampal NSCs, we performed scRNA-seq of <italic>Mycn</italic> cKO mice and controls, in a design that mirrored that of <italic>Ascl1</italic> and <italic>Huwe1</italic> cKO experiments (<xref ref-type="fig" rid="F3">Figure 3A</xref>). In total, across two independent experimental replicates, we sequenced 9,187 <italic>Mycn</italic> cKO cells and 6,845 control cells. Consistent with our immunolabelling data (<xref ref-type="supplementary-material" rid="SD5">Figure S2C; Figure S3D</xref>), an increased percentage of cells from <italic>Mycn</italic> cKO mice were quiescent NSCs compared to controls (62.3% versus 31.4%), and there were also fewer neuroblasts (22.5% versus 50.4%) (<xref ref-type="fig" rid="F3">Figure 3B-D</xref>). To test how MYCN might affect NSC activation we then re-clustered the scRNA-seq data to only include NSCs (<xref ref-type="fig" rid="F3">Figure 3E</xref>) and then only quiescent cells and organised them into a pseudotime trajectory (<xref ref-type="fig" rid="F3">Figure 3F</xref>). Unlike NSCs from <italic>Ascl1</italic> cKO mice, which accumulated in deep states of quiescence, the <italic>Mycn</italic> cKO cells entirely overlapped with control cells. However, <italic>Mycn</italic> cKO were not phenotypically normal, instead they demonstrated a distinct phenotype, whereupon they accumulated approximately halfway along the pseudotime trajectory (<xref ref-type="fig" rid="F3">Figure 3F</xref>). These data suggest that while both <italic>Ascl1</italic> and <italic>Mycn</italic> deletion leads to a loss or decrease in stem cell activation, these phenotypes arise, at least in part, through different cellular mechanisms. <italic>Ascl1</italic> loss principally hinders the ability of cells to leave deep quiescence, whereas loss of <italic>Mycn</italic> impedes progression through shallow quiescence. Consistent with this, using tradeSeq<sup><xref ref-type="bibr" rid="R25">25</xref>,<xref ref-type="bibr" rid="R26">26</xref></sup> we found that the number of differentially expressed genes between Ascl1 <italic>cKO</italic> mice and controls were highest during early phases of pseudotime (deep quiescence, defined as cells positioned prior to the median pseudotime position of <italic>Ascl1</italic> control cells), while the number of differentially expressed genes in <italic>Mycn</italic> cKO mice and controls was highest in shallow quiescence (defined as cells positioned after the median pseudotime position of <italic>Mycn</italic> control cells) (<xref ref-type="supplementary-material" rid="SD5">Figure S4B, E</xref>).</p></sec><sec id="S6"><title>Sequential Ascl1-Mycn programs govern NSC activation</title><p id="P14">The roles of ASCL1 and MYCN in promoting progression towards an active state from deep and shallow states of quiescence respectively, suggested that ASCL1 might induce the expression of MYCN during the activation process. Consistent with this, <italic>Ascl1</italic> mRNA levels increase dramatically prior to the induction of <italic>Mycn</italic> mRNA (<xref ref-type="fig" rid="F4">Figure 4A, B</xref>). To explore this relationship further, we performed differential expression analysis on NSCs from <italic>Ascl1</italic> cKO mice and controls using a pseudo-bulk approach (<xref ref-type="supplementary-material" rid="SD2">Table S2</xref>). In NSCs from <italic>Ascl1</italic> cKO mice, <italic>Mycn</italic> was the second most strongly downregulated transcription factor in the dataset (<xref ref-type="fig" rid="F4">Figure 4C, D</xref>; <xref ref-type="supplementary-material" rid="SD2">Table S2</xref>). We verified MYCN was also downregulated at a protein level in quiescent NSCs from <italic>Ascl1 cKO</italic> mice compared to controls (<xref ref-type="fig" rid="F4">Figure 4E, F</xref>). Similarly, we performed differential expression analysis of NSCs from <italic>Huwe1</italic> cKO mice and controls (<xref ref-type="supplementary-material" rid="SD3">Table S3</xref>). In this analysis, loss of <italic>Huwe1</italic> led to a strong upregulation of <italic>Mycn</italic> (<xref ref-type="fig" rid="F4">Figure 4G, H</xref>). Furthermore, we analysed a previously published ChIP-sequencing dataset of ASCL1 binding in hippocampal NSC cultures and found an ASCL1 peak overlapping with active enhancer marks P300 and H3K27ac in an intronic region of the <italic>Mycn</italic> gene (<xref ref-type="fig" rid="F4">Figure 4I</xref>)<sup><xref ref-type="bibr" rid="R9">9</xref></sup>. Together, these data demonstrate that ASCL1 promotes the expression of <italic>Mycn</italic> during hippocampal NSC activation, likely through direct transcriptional activation.</p><p id="P15">We next sought to compare the transcriptional programs controlled by Ascl1 during deep quiescence and Mycn during shallow quiescence. To do this we performed differential expression analysis between cKO and control only on the quiescent NSC fraction from both the <italic>Ascl1</italic> datasets (<xref ref-type="supplementary-material" rid="SD2">Table S2</xref>, 158 differentially expressed genes) and <italic>Mycn</italic> datasets (<xref ref-type="supplementary-material" rid="SD4">Table S4</xref>, 92 differentially expressed genes). Gene ontology (GO) enrichment analysis of biological process terms (<xref ref-type="supplementary-material" rid="SD2">Table S2</xref>) revealed that loss of <italic>Ascl1</italic> led to enrichment of the <italic>notch signalling pathway</italic> (e.g., downregulation of genes <italic>Dll1, Notch1/2, Hes5</italic>) and <italic>positive regulation of Cyclin-dependent protein serine/threonine kinase activity</italic> (e.g., downregulation of <italic>Ccnd1/2</italic> and <italic>Egfr</italic> genes). Loss of <italic>Ascl1</italic> also led to enrichment of <italic>regulation of BMP signalling pathway</italic>, including decreased expression of BMP antagonist <italic>Nbl1</italic> and altered expression of genes associated with <italic>Cell-substrate adhesion</italic> and <italic>Mitochondrial membrane potential</italic> (<italic>Ndufc2, Mfn1</italic>). In contrast, loss of <italic>Mycn</italic> resulted led to enriched GO terms relating to biosynthesis, specifically GO terms such as <italic>cytoplasmic translation</italic> (e.g., downregulation of <italic>Rpl29, Rps12, Rps8</italic> genes) and <italic>regulation of transcription from RNA polymerase II promoter in response to stress</italic> (e.g., <italic>Egr1, Klf2, Pppr1r15a</italic>) and (<xref ref-type="supplementary-material" rid="SD4">Table S4</xref>). No ribosomal genes or mRNA processing pathways were enriched in the <italic>Ascl1</italic> dataset (<xref ref-type="supplementary-material" rid="SD2">Table S2</xref>). These analyses demonstrate a clear separation of roles where ASCL1 promotes activation from deep quiescence by modulating the activity of key signalling pathways (e.g., cell adhesion and <italic>BMP</italic> signalling and metabolic modulation through mitochondria membrane potential)<sup><xref ref-type="bibr" rid="R27">27</xref>–<xref ref-type="bibr" rid="R29">29</xref></sup>, whereas MYCN promotes activation from shallow quiescence by increasing transcription and translation<sup><xref ref-type="bibr" rid="R18">18</xref></sup>.</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P16">Quiescence is not a uniform cellular state; rather, it exists as a continuous spectrum of varying degrees of depth. Transitions between deep and shallow states of quiescence have been associated with the degree of lysosomal activity and autophagic flux<sup><xref ref-type="bibr" rid="R30">30</xref></sup>. However, outside of this, relatively little is known about the ordering of events during these transitions, including in the adult nervous system. Using scRNA-seq we have demonstrated that these transitions can be separated into distinct phases in quiescent hippocampal NSCs, where sequential activation of ASCL1 and MYCN transcription factors lead to NSC activation.</p><p id="P17">Prior work has focussed on the role of ASCL1 in active NSCs<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref></sup>, whereas our analysis has demonstrated a role for ASCL1 in quiescent NSCs. Specifically, our data demonstrates that ASCL1 is required to promote the progression of hippocampal NSCs from deep states to shallow states of quiescence. We have previously observed ASCL1 levels decline during aging and this is correlated with an accumulation of hippocampal NSCs in deep states of quiescence<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Our new data further strengthens the argument that this is a causal relationship. The role for ASCL1 in promoting activation from deep states of quiescence may appear surprising because ASCL1 protein is typically only detected in active NSCs when using conventional antibody staining techniques. However, despite being broadly transcribed, ASCL1 is typically only detected in active NSCs because it undergoes proteasomal degradation due to destabilisation by inhibitor of DNA binding (ID) transcription factor proteins in quiescent NSCs<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. Despite these post-translational mechanisms controlling ASCL1 levels in quiescent NSCs, it is clear that small amounts of protein are produced. For example, using sensitive antibodies against a VENUS fusion protein we have previously detected ASCL1 protein in more than 50% of quiescent NSCs, at least in young mice<sup><xref ref-type="bibr" rid="R11">11</xref></sup>.</p><p id="P18">Conversely, we found that the <italic>Mycn</italic> transcription factor promotes activation from shallow states of quiescence. <italic>Mycn</italic> appears to be important in increasing biosynthesis, consistent with its role in other systems such as in embryonic diapause<sup><xref ref-type="bibr" rid="R20">20</xref></sup> or in quiescent haematopoietic stem cells<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. We analysed conditional genetic knockout mice of <italic>Mycn, Myc</italic> and <italic>Mycl</italic> side-by-side and only observed significant defects in <italic>Mycn</italic> mice, and the phenotype of triple knockout mice was comparable to loss of <italic>Mycn</italic> alone. While we cannot rule out minor roles for <italic>Myc/Mycl</italic> in the activation process, indeed <italic>Myc</italic> has recently been suggested to have a role in promoting hippocampal NSC activation<sup><xref ref-type="bibr" rid="R31">31</xref></sup>, clearly <italic>Mycn</italic> is the dominant family member in this context.</p><p id="P19">These sequential transcriptional programs governing progression from deep quiescence to shallow quiescence are likely linked through direct transcriptional regulation, where ASCL1 activates the expression of MYCN. ASCL1 has previously been shown to transcriptionally regulate MYCN in other scenarios. For example, MYCN is a target gene of ASCL1 in glioblastoma<sup><xref ref-type="bibr" rid="R32">32</xref></sup>. Similarly, in neuroblastoma, ASCL1 acts as a pioneer factor where it then recruits and cooperates with MYCN at genomic loci to drive adrenergic cell fate conversion<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. Whether ASCL1 and MYCN also drive gene expression in a cooperative manner in quiescent NSCs is unclear, although relatively few genes were commonly mis-regulated between both datasets, which would argue for limited cooperation. Regardless of the exact functional relationship between these transcription factor proteins, a useful mRNA combinatorial code can be generated to classify hippocampal NSCs into deep states of quiescence (<italic>Ascl1</italic>+<italic>Mycn-Ki67</italic>-), shallow states of quiescence (<italic>Ascl1+Mycn+Ki67-</italic>) and active states (<italic>Ki67+</italic>). Future studies should explore whether <italic>Ascl1</italic>+<italic>Mycn+Ki67–</italic> hippocampal NSCs encompass all cells in shallow quiescence or whether populations such as resting NSCs<sup><xref ref-type="bibr" rid="R6">6</xref></sup> and primed NSCs<sup><xref ref-type="bibr" rid="R4">4</xref></sup> represent distinct populations.</p><sec id="S8"><title>Limitations of study</title><p id="P20">Interestingly, MYCN also serves as a substrate for HUWE1-mediated ubiquitination during embryonic brain development<sup><xref ref-type="bibr" rid="R34">34</xref></sup>. While our prior work established ASCL1 as the primary target of HUWE1 in hippocampal NSCs<sup><xref ref-type="bibr" rid="R10">10</xref></sup>, the possibility that elevated MYCN protein levels contribute to the phenotype observed in HUWE1 knockout mice cannot be entirely ruled out. However, our conditional deletion of the <italic>Mycn</italic> gene demonstrates that the primary function of <italic>Mycn</italic> is to promote progression through shallow quiescence.</p></sec></sec><sec id="S9" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S10"><title>Lead contact</title><p id="P21">Further information and requests for reagents should be directed to and will be fulfilled by the Lead Contact, Lachlan Harris (<email>Lachlan.harris@qimrberghofer.edu.au</email>).</p></sec><sec id="S11"><title>Materials availability</title><p id="P22">This study did not generate new reagents.</p></sec></sec><sec id="S12"><title>Experimental Model and Subject Details</title><p id="P23">All mice were maintained on a mixed genetic background. The Ascl1 cKO<sup><xref ref-type="bibr" rid="R9">9</xref></sup>, Myc cKO<sup><xref ref-type="bibr" rid="R21">21</xref></sup>, MycN cKO<sup><xref ref-type="bibr" rid="R22">22</xref></sup>, MycL cKO<sup><xref ref-type="bibr" rid="R23">23</xref></sup>; Nestin-GFP<sup><xref ref-type="bibr" rid="R36">36</xref></sup>, YFP<sup><xref ref-type="bibr" rid="R12">12</xref></sup> and Glast-creERT2<sup><xref ref-type="bibr" rid="R13">13</xref></sup> transgenic lines have all been previously reported. Both male and female mice were used throughout the study, an exception to this was for the x-linked Huwe1 conditional allele, where only males were used. The effects of the gene knockouts seen throughout the study were consistent across sexes. All experimental protocols involving mice were performed in accordance with guidelines of the Francis Crick Institute, national guidelines and laws. This study was approved by the UK Home Office (PPL PB04755CC). Throughout the study, mice were housed in standard cages with a 12 h light/dark cycle and ad libitum access to food and water.</p></sec><sec id="S13"><title>Method Details</title><sec id="S14"><title>Preparation and sectioning of mouse brain tissue</title><p id="P24">Mice were perfused transcardially with phosphate buffered saline (PBS), followed by 4% paraformaldehyde (10-20 mL) and postfixed for 16-24 h before long term storage in PBS with 0.02% sodium azide, at 4°C. Brains were sectioned in a coronal plane at 40 μm using a vibratome (Leica). The entire rostral-caudal extent of the hippocampus was collected in a 1 in 12 series.</p></sec><sec id="S15"><title>Antibodies, immunofluorescence, cell counts</title><p id="P25">At minimum, 1 series per mouse (5-6 sections) was stained and analysed per experiment. Free-floating sections underwent antigen retrieval in sodium citrate solution (10mM, pH6.0) for 10min at 95°C. The retrieval time was reduced if the detection of endogenous YFP/GFP was required, as these proteins are heat sensitive and cannot be re-detected with commercially available antibodies against GFP <sup><xref ref-type="bibr" rid="R37">37</xref></sup>. Sections were blocked with normal donkey serum (2%) diluted in PBS-Triton X-100 (0.2%) for a minimum of 2 h. Sections were then incubated overnight at 4°C with primary antibodies diluted in blocking buffer. After three washes in PBS for 10 min, the sections were incubated with fluorescent secondary antibodies at room temperature for 2 h (Jackson ImmunoResearch). The sections were counterstained with 4’,6-diamidino-2-phenylindole (DAPI, ThermoFisher Scientific) and mounted onto Superfrost slides.</p><p id="P26">The sections were imaged using a SP5/SP8 Leica confocal microscope with a 40X objective or a Olympus CSU-W1 SoRa spinning disc confocal using a 20X objective. Cell counts were then performed, data was normalised to number of cells per surface area of subgranular zone, which was measured by the length of the subgranular zone in coronal brain sections multiplied by the thickness of the vibratome section. In all analyses, we identified NSCs as those cells that had a radial GFAP-positive process that we could confidently link to a SOX2-positive nucleus in the subgranular zone (SGZ). The cells were classified as quiescent or proliferating depending on the expression of Ki67. To calculate the proportion of NSCs expressing MYCN in control mice at minimum 20 quiescent and proliferating NSCs were examined per animal. To calculate the proportion of NSCs expressing MYCN in <italic>Ascl1</italic> cKO versus <italic>Ascl1</italic> control mice a minimum of 40 cells were examined per animal. Cell counts were not performed blinded to genotype, as the severe phenotypes of <italic>Ascl1</italic>, <italic>Huwe1</italic>, <italic>Mycn</italic>, and triple <italic>Myc</italic> cKO mice made blinding of images impractical.</p></sec><sec id="S16"><title>Tamoxifen treatment</title><p id="P27">Tamoxifen solution (10-20 mg/mL) was prepared for oral gavage by dissolving the powder (Sigma-Aldrich) in a mix of 10% ethanol and 90% cornflower oil (Sigma-Aldrich) and was provided to mice via oral gavage (100 mg/kg).</p></sec><sec id="S17"><title>Single-cell RNA sequencing</title><sec id="S18"><title>Sample Preparation</title><p id="P28">Each independent scRNA-seq experiment (batch) comprised a pooled group of 1-2 conditional knockout mice (of either <italic>Ascl1</italic>, <italic>Huwe1</italic> or <italic>Mycn cKO</italic> genotype) with 1-2 littermate controls that were prepared simultaneously to minimise processing artefacts. In total, 3 independent experiments were performed on <italic>Ascl1</italic> cKO mice and controls, 2 independent experiments on <italic>Huwe1</italic> cKO mice and controls and 2 independent experiments on <italic>Mycn</italic> cKO mice and controls (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). In the <italic>Ascl1</italic> experiments, the cKO mice were homozygous for the floxed allele, heterozygous for Glast-creERT2 and homozygous for the cre-reporter YFP allele, while the the control mice were genetically identical but were wildtype for <italic>Ascl1</italic> alleles. In the <italic>Huwe1</italic> experiments, the male cKO mice were hemizygous for the floxed allele, heterozygous for Glast-creERT2 and homozygous for the cre-reporter YFP allele, while the male control mice were genetically identical but were wildtype for <italic>Huwe1</italic>. All mice received tamoxifen via oral gavage (100mg/kg) for 5 days starting from P30 (range from P27-P33) and were euthanised 12-days later. For the <italic>Mycn</italic> experiments, the cKO and control mice were homozygous for the floxed allele, heterozygous for Glast-creERT2 and heterozygous for Nestin-GFP. The <italic>Mycn</italic> cKO mice received tamoxifen and <italic>Mycn</italic> control mice received corn-oil via oral gavage for 5-days at P30 (range from P27-P30) before being euthanised 12-days later. In the majority of experiments, at least two cKO or control mice were combined to guarantee the sorting and sequencing of sufficient numbers of cells (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>).</p><p id="P29">Mice were euthanised by cervical dislocation, and the hippocampal dentate gyri were dissected<sup><xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R39">39</xref></sup>. The dentate gyrus was disassociated using the Neural Tissue dissociation kit (P) (Milteny Biotec) with the following exceptions, a 37C orbital shaker was used during the enzymatic digestions, and we used manual trituration with fire-polished pipettes to aid dissociation following the incubations with enzymatic mix 1 and 2<sup>6</sup>. Cells were also live-dead counterstained with DAPI. The cells were then sorted on a MoFlo XDP (Bechman Coulter) using a 100 μm nozzle. Debris were removed, followed by two gates to remove aggregates and dead cells, based on DAPI fluorescence. Cells were then gated for YFP or GFP expression according to cells from a control mouse hippocampus that did not contain a fluorescent transgene. We sorted between 10,000-25,000 cells per group (2 mice per group) over a period of 15-30 min per sample. The cells were sorted into 700 μl of recovery media (0.5% PBS-BSA in DMEM/F-12 without phenol red) in 1.5mL tubes, and spun down at 500 <italic>g</italic> for 7 min at 4°C.</p><p id="P30">The cells were then gently resuspended in the residual recovery media using a wide-bore pipette to a final volume of 50 μl. The single-cell suspension (to a maximum of 10,000 cells) was then loaded into the 10x Chromium.</p></sec><sec id="S19"><title>Sequencing and data processing</title><p id="P31">On each experimental day, two libraries were prepared, one for each of the experimental groups to control for batch effects, which are strong in this type of data (i.e., cKO and control). All libraries were prepared with 10x Genomics Chemistry, Single Cell version 3.0.1. After sequencing, cellranger count (Ver. 7.0.1) was used to map the FASTQ files from the Ascl1 and Huwe1 experiment to refdata-gex-mm10-2020-A. In contrast, the Mycn data was mapped to a custom version of this genome, which had the <italic>Mycn</italic> gene deleted and replaced with two new contigs, corresponding to exon1 of the <italic>Mycn</italic> gene (<italic>Mycnex1</italic>) and exon 2/3 (<italic>Mycnex3</italic>). This modification was made to detect cells that had undergone recombination of the <italic>Mycn</italic> locus. Specifically, in control cells, the majority of reads map to the exon 2 and 3 of the <italic>Mycn</italic> locus, which are directly upstream of the polyA tail. In contrast, in cells that have recombined <italic>Mycn</italic>, exons 2 and 3 are deleted, and all reads map to exon 1. The gene encoding eGFP was also added to the custom genome. The genome was made with the cellranger mkref command. As both males and female mice were used in this study but sex differences were not the focus of our investigation, the Y chromosome genes with highest expression (<italic>Eif2s3y</italic>, <italic>Ddx3y</italic>, <italic>Gm47283</italic>, <italic>Uty</italic> and <italic>Kdm5d)</italic> and genes involved in X-inactivation (<italic>Xist</italic> and <italic>Tsix</italic>) were deleted from the count matrices prior to normalisation and clustering.</p></sec><sec id="S20"><title>Quality control</title><p id="P32">Individual samples were read into R version 4.2.0 and analysed using Seurat (Ver. 4.3.0.1)<sup><xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup>. Unless otherwise specified, plots were created using ggplot2 version 3.4.2. GEM beads were excluded if they nCount_RNA values were less than 600-5000 (varied according to distribution of data within individual samples) or had greater than 8% mitochondrial reads (uniform across all samples). In total, 77.9% of cells passed quality control in Ascl1 data, 78.8% in Huwe1 data, and 94.9% in Mycn data. In the second <italic>Ascl1</italic> cKO replicate (comprising 1 male, 1 female) we found that a female mouse from the control group (compromising 1 male, 1 female) had been inadvertently swapped with the female <italic>Ascl1</italic> cKO mouse. Cells from the <italic>Ascl1</italic> cKO and control samples were reassigned to their correct experimental groups by first identifying the individual mouse each cell originated from, based on sex-specific gene expression. To do this, a sex score was calculated by subtracting raw counts of the sum of female genes involved in X-inactivation (<italic>Xist</italic> and <italic>Tsix</italic>) from Y chromosome genes (<italic>Ddx3y</italic>, <italic>Uty</italic> and <italic>Eif2s3y</italic>). A negative sex score indicated female sex and a score of ≥ 0 indicated male sex. Subsequently, the cells were assigned to the appropriate genotype by confirming the presence or absence of <italic>Ascl1</italic> expression.</p></sec><sec id="S21"><title>Normalisation, dimensionality reduction and clustering</title><p id="P33">All <italic>Ascl1</italic> cKO and control samples were merged into one large Seurat object. Separately, this was repeated for all <italic>Huwe1</italic> samples and all <italic>Mycn</italic> samples. The merged Seurat objects were then split according to experimental replicate using the function SplitObject and the data transformed using the SCTransform function, with the vst.flavor argument set to “v2”. The data was integrated using the function SelectIntegrationFeatures with the nFeatures argument set to “3000” and the functions PrepSCTIntegration, FindIntegrationAnchors and IntegrateData using default parameters to control for batch effects between experimental days. Elbow plots were used to approximate the number of principal components for clustering and visualisation using UMAP plots<sup><xref ref-type="bibr" rid="R42">42</xref></sup>. As axis values of UMAPs are not meaningful, we orientated the final plots so that active NSC clusters appear towards the top-right of each plot and/or differentiation processes proceed from left-to-right.</p><p id="P34">After identification of clusters, we isolated the three neurogenic clusters according to known marker expression, quiescent NSCs (<italic>Hopx</italic>-high, <italic>S100b</italic>-low), proliferating cells (containing cell-cycle markers, NSC markers and intermediate progenitor cell markers), and neuroblasts (Dcx-high, Eomes-low). After isolating these cells, we used the SCTransform workflow to recluster these populations. Next, we sought to isolate only NSCs. As previously described, the proliferating cell cluster contained both proliferating NSCs and intermediate progenitor cells<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Therefore, we next separated proliferating NSCs from intermediate progenitor cells based on marker expression (<italic>Hopx/Apoe-</italic> high, <italic>Dcx/Neurod2-</italic>negative; <italic>Eomes/Tubb3</italic>-low) and reiterated the SCTransform workflow. We repeated this process by removing proliferating NSCs and reclustered a final time. The result was four Seurat objects (all cells, neurogenic clusters, NSCs and quiescent NSCs) per <italic>Ascl1</italic>, <italic>Huwe1</italic> and <italic>Mycn</italic> data set. For downstream trajectory inference and pseudobulk analysis, Seurat objects were converted to SingleCellExperiment objects using the Seurat function as.SingleCellExperiment with the assay argument set to “RNA”.</p></sec><sec id="S22"><title>Pseudo-bulk differential expression analysis</title><p id="P35">A pseudo-bulk approach was used to perform differential gene expression analysis between cKO and control conditions. Pseudo-bulk samples were created by aggregating counts across individual samples using the scuttle (version 1.8.4) function aggregateAcrossCells. Differential expression analysis was performed using the scran (version 1.26.2) function pseudoBulkDGE, which is a wrapper for edgeR’s quasi-likelihood methods. To run pseudoBulkDGE, the “edgeR” method was used, and batch effects between biological replicates (experiments) were accounted for using the design formula “~Batch + Genotype”, where Batch represented the biological replicate, and Genotype represented cKO or control. Differentially expressed genes were determined using false discovery rate (FDR) &lt; 0.05. Transcription Factor (TF) status (0 and 1) of each gene was determined based on a previously published classification<sup><xref ref-type="bibr" rid="R43">43</xref></sup>.</p></sec><sec id="S23"><title>Gene Ontology enrichment analysis</title><p id="P36">Gene Ontology (GO) enrichment analysis was performed using clusterProfiler (version 4.6.2)<sup><xref ref-type="bibr" rid="R44">44</xref></sup>. First, gene symbols for differentially expressed genes identified by pseudo-bulk analysis were converted to Entrez IDs using the bitr function. The Entrez IDs were then passed to the enrichGO function with ont argument set to “BP” (Biological Process category). Significant terms were determined using FDR &lt; 0.05.</p></sec><sec id="S24"><title>Pseudotime analysis</title><p id="P37">For pseudotime analysis the quiescent NSC Seurat objects were used. The quiescent NSCs were ordered from deep to shallow quiescence using the pseudotime inference tool Slingshot version 2.6.0<sup><xref ref-type="bibr" rid="R17">17</xref></sup>. Specifically, the slingshot function was used with reducedDim argument set to PCA. To ensure the orientation of the trajectory was correct, we assessed the expression of quiescence marker genes (<italic>Apoe</italic>, <italic>Clu</italic>, Hopx, <italic>Id4</italic> and <italic>Sparc</italic>) and activation marker genes (<italic>Ccnd1</italic>, <italic>Ccnd2</italic>, <italic>Rpl10</italic> and <italic>Thrsp</italic>), where we expect increased expression of the markers at the start and end of the trajectory, respectively. Whilst Slingshot automatically placed the trajectory for the <italic>Mycn</italic> samples in the correct orientation, the trajectory for the <italic>Ascl1</italic> samples was in the reverse orientation. To overcome this, we created manual cluster labels based on Seurat clusters, where all but the Seurat cluster that should be the end cluster was labelled as one cluster. These manual cluster annotations were then used for the clusterLabels argument to run slingshot.</p></sec><sec id="S25"><title>Trajectory-based differential expression analysis</title><p id="P38">Downstream of trajectory inference, we performed trajectory-based differential expression analysis between experimental groups (cKO versus control) using tradeSeq version 1.12.02<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R26">26</xref></sup>. First, we evaluated the number of knots to use for the negative binomial generalised additive models (NB-GAMs) with the evaluateK function using default settings. Based on the graphical output from evaluateK, we purposely chose the same number of knots (6 knots) across the <italic>Ascl1</italic> and <italic>Mycn</italic> experiments to enable comparisons. Next, we ran the fitGAM function to fit NB-GAMs to the SingleCellExperiment data, with nknots = 6 and conditions argument specifying Genotype (cKO and control). Knots were visualised in reduced dimensions (PCA) using plotGeneCount. We then ran the conditionTest function multiple times to test for differential expression between experimental groups along pseudotime. For conditionTest, we used l2fc value of log2(1.2), as we found hundreds to thousands of significant genes without such a threshold, and for each test we contrasted sequential knots using the knots argument (vector of two), namely knots 1 vs 2, 2 vs 3, 3 vs 4, 4 vs 5, 5 vs 6. Results were sorted by descending Wald statistic, and p-values were adjusted using p.adjust “fdr” method. Significant genes were determined using FDR &lt; 0.05, and visualized using plotSmoothers.</p></sec><sec id="S26"><title>ChIP-sequencing analysis</title><p id="P39">The ASCL1 ChIPseq fastq file (ERR376162) was obtained from Andersen and colleagues <sup><xref ref-type="bibr" rid="R9">9</xref></sup> (deposited in the European Nucleotide Archive’s Sequence Read Archive under accession number ERP004380), the p300 (ERR216112) and H3K27ac (ERR216108) ChIPseq fastq files were obtained from Martynoga and colleagues<sup><xref ref-type="bibr" rid="R35">35</xref></sup> (deposited in the European Nucleotide Archive’s Sequence Read Archive under accession number ERP002084).</p><p id="P40">Raw reads data were quality-controlled using FastQC (v. 0.11.8). Reads were aligned using Bowtie2 (v. 2.5.1) to the mm10 mouse reference genome using default parameters. Samtools (v.1.18) was then used to convert sam files to bam format. Sambamba (v. 0.6.6) was used to sort bam files by genomic coordinates and filter out PCR duplicates and unmapped reads to contain only uniquely mapping reads. deepTools (v. 3.5.1) was used to obtain the bigWig files.</p></sec></sec></sec><sec id="S27"><title>Quantification and Statistical Analysis</title><sec id="S28"><title>Statistical analysis of cell counts</title><p id="P41">The statistical testing approach were implemented using Graphpad Prism (version 8.0) or in R (4.2.0). Two-tailed unpaired Student’s t tests were performed when comparing two groups. For experiments involving two independent variables, a two-way ANOVA was performed. Any significant main effect detected by ANOVA was followed by multiple comparisons analysis using multiple t-test and a pooled estimate of variance where appropriate with Holm-Sidak correction.</p></sec><sec id="S29"><title>Single-cell data</title><p id="P42">To determine if the distribution of quiescent NSCs along pseudotime were different between experimental groups, a Kolmogorov-Smirnov test was performed with function ks.test in R (4.2.0).</p></sec><sec id="S30"><title>List of antibodies</title><table-wrap id="T1" position="anchor" orientation="portrait"><table frame="box" rules="all"><thead><tr><th align="left" valign="top">REAGENT or RESOURCE</th><th align="left" valign="top">Source</th><th align="left" valign="top">Identifier</th></tr></thead><tbody><tr><td align="left" valign="top">Rat monoclonal anti-GFAP</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">RRID:AB_86543</td></tr><tr><td align="left" valign="top">Chicken polyclonal anti-GFP</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">RRID:AB_300798</td></tr><tr><td align="left" valign="top">Mouse monoclonal anti-Ki67</td><td align="left" valign="top">BD Biosciences</td><td align="left" valign="top">RRID:AB_393778</td></tr><tr><td align="left" valign="top">Rat monoclonal anti-SOX2</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">RRID:AB_11219471</td></tr><tr><td align="left" valign="top">Goat polyclonal anti-DCX</td><td align="left" valign="top">Santa Cruz Biotechnology</td><td align="left" valign="top">RRID:AB_2088494</td></tr><tr><td align="left" valign="top">Rabbit monoclonal anti-MYCN</td><td align="left" valign="top">Cell Signalling</td><td align="left" valign="top">RRID:AB_2800038</td></tr><tr><td align="left" valign="top">Alexa Fluor 488-affiniPure F(ab’)2 Donkey anti-mouse IgG</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">RRID:AB_2340849</td></tr><tr><td align="left" valign="top">Alexa Fluor 488-affiniPure F(ab’)2 Donkey anti-rabbit IgG</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">RRID:AB_2340619</td></tr><tr><td align="left" valign="top">Alexa Fluor 488-affiniPure F(ab’)2 Donkey anti-rat IgG</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">RRID:AB_2340686</td></tr><tr><td align="left" valign="top">Alexa Fluor Cy3-affiniPure F(ab’)2 Donkey anti-rat IgG</td><td align="left" valign="top">JacksonImmunoResearch</td><td align="left" valign="top">RRID:AB_2340669</td></tr><tr><td align="left" valign="top">Alexa Fluor Cy3-affiniPure F(ab’)2 Donkey anti-goat IgG</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">RRID:AB_2340413</td></tr><tr><td align="left" valign="top">Alexa Fluor 647-affiniPure F(ab’)2 Donkey anti-mouse IgG</td><td align="left" valign="top">JacksonImmunoResearch</td><td align="left" valign="top">RRID:AB_2340866</td></tr><tr><td align="left" valign="top">Alexa Fluor 647-affiniPure F(ab’)2 Donkey anti-rabbit IgG</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">RRID:AB_2340625</td></tr><tr><td align="left" valign="top">Alexa Fluor 647-affiniPure F(ab’)2 Donkey anti-rat IgG</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">RRID:AB_2340695</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Table_S1</label><media xlink:href="EMS199808-supplement-Table_S1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d44aAcHbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Table_S2</label><media xlink:href="EMS199808-supplement-Table_S2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d44aAcHcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Table_S3</label><media xlink:href="EMS199808-supplement-Table_S3.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d44aAcHdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Table_S4</label><media xlink:href="EMS199808-supplement-Table_S4.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d44aAcHeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplemental Items</label><media xlink:href="EMS199808-supplement-Supplemental_Items.pdf" mimetype="application" mime-subtype="pdf" id="d44aAcHfB" position="anchor"/></supplementary-material></sec></body><back><ack id="S31"><title>Acknowledgments</title><p>We gratefully acknowledge Lan Chen and the Biological Resources, Advanced Sequencing, Flow Cytometry, and Light Microscopy Facilities; and the Research Illustration team of the Francis Crick Institute for technical support. This work was supported by the Francis Crick Institute, which receives its funding from Cancer Research UK (FC0010089), the UK Medical Research Council (FC0010089), and the Wellcome Trust (FC0010089). This work was also supported by QIMR Berghofer.</p></ack><sec id="S32" sec-type="data-availability"><title>Data and code availability</title><p id="P43">scRNA-seq sequencing files (FASTQs), cellranger outputs and original code will be made available upon publication.</p></sec><fn-group><fn id="FN3" fn-type="con"><p id="P44"><bold>Author contributions</bold></p><p id="P45">Conceptualization, F.G and LH; Data Curation, L.H.; Formal Analysis, L.H., P.R., S.A.P., R.L.J., C.C; Investigation, L.H., P.R., S.A.P., R.L.J., Visualization, L.H., P.R., S.A.P., R.L.J., Methodology, L.H., R.L.J., F.G.; Writing – Original Draft, L.H.; Writing – Review &amp; Editing, all authors; Supervision, F.G. and L.H.; Funding Acquisition, F.G. and L.H.; Project Administration, L.H.</p></fn><fn id="FN4" fn-type="conflict"><p id="P46"><bold>Declaration of interests</bold></p><p id="P47">The authors declare no competing interests</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>JT</given-names></name><name><surname>King</surname><given-names>KY</given-names></name><name><surname>Brett</surname><given-names>JO</given-names></name><name><surname>Cromie</surname><given-names>MJ</given-names></name><name><surname>Charville</surname><given-names>GW</given-names></name><name><surname>Maguire</surname><given-names>KK</given-names></name><name><surname>Brunson</surname><given-names>C</given-names></name><name><surname>Mastey</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Tsai</surname><given-names>CR</given-names></name><etal/></person-group><article-title>mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert)</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>393</fpage><lpage>396</lpage><pub-id pub-id-type="pmcid">PMC4065227</pub-id><pub-id pub-id-type="pmid">24870234</pub-id><pub-id pub-id-type="doi">10.1038/nature13255</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>JT</given-names></name><name><surname>Schroeder</surname><given-names>MD</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name></person-group><article-title>HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of Stem Cells into G(Alert)</article-title><source>Cell Rep</source><year>2017</year><volume>19</volume><fpage>479</fpage><lpage>486</lpage><pub-id pub-id-type="pmcid">PMC5468096</pub-id><pub-id pub-id-type="pmid">28423312</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.066</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>DI</given-names></name><name><surname>Both</surname><given-names>P</given-names></name><name><surname>Benjamin</surname><given-names>JS</given-names></name><name><surname>Nutter</surname><given-names>CW</given-names></name><name><surname>Tan</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Machado</surname><given-names>LA</given-names></name><name><surname>Klein</surname><given-names>JDD</given-names></name><name><surname>de Morree</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><etal/></person-group><article-title>Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling</article-title><source>Cell Metab</source><year>2022</year><volume>34</volume><fpage>902</fpage><lpage>918</lpage><elocation-id>e906</elocation-id><pub-id pub-id-type="pmcid">PMC9177797</pub-id><pub-id pub-id-type="pmid">35584694</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2022.04.012</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llorens-Bobadilla</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Baser</surname><given-names>A</given-names></name><name><surname>Saiz-Castro</surname><given-names>G</given-names></name><name><surname>Zwadlo</surname><given-names>K</given-names></name><name><surname>Martin-Villalba</surname><given-names>A</given-names></name></person-group><article-title>Single-Cell Transcriptomics Reveals a Population of Dormant Neural Stem Cells that Become Activated upon Brain Injury</article-title><source>Cell Stem Cell</source><year>2015</year><volume>17</volume><fpage>329</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">26235341</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Bottes</surname><given-names>S</given-names></name><name><surname>Fisch</surname><given-names>R</given-names></name><name><surname>Zehnder</surname><given-names>C</given-names></name><name><surname>Cole</surname><given-names>JD</given-names></name><name><surname>Pilz</surname><given-names>GA</given-names></name><name><surname>Helmchen</surname><given-names>F</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name><name><surname>Jessberger</surname><given-names>S</given-names></name></person-group><article-title>Chronic in vivo imaging defines agedependent alterations of neurogenesis in the mouse hippocampus</article-title><source>Nat Aging</source><year>2023</year><volume>3</volume><fpage>380</fpage><lpage>390</lpage><pub-id pub-id-type="pmcid">PMC10154232</pub-id><pub-id pub-id-type="pmid">37117787</pub-id><pub-id pub-id-type="doi">10.1038/s43587-023-00370-9</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>L</given-names></name><name><surname>Rigo</surname><given-names>P</given-names></name><name><surname>Stiehl</surname><given-names>T</given-names></name><name><surname>Gaber</surname><given-names>ZB</given-names></name><name><surname>Austin</surname><given-names>SHL</given-names></name><name><surname>Masdeu</surname><given-names>MDM</given-names></name><name><surname>Edwards</surname><given-names>A</given-names></name><name><surname>Urban</surname><given-names>N</given-names></name><name><surname>Marciniak-Czochra</surname><given-names>A</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name></person-group><article-title>Coordinated changes in cellular behavior ensure the lifelong maintenance of the hippocampal stem cell population</article-title><source>Cell Stem Cell</source><year>2021</year><volume>28</volume><fpage>863</fpage><lpage>876</lpage><elocation-id>e866</elocation-id><pub-id pub-id-type="pmcid">PMC8110946</pub-id><pub-id pub-id-type="pmid">33581058</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2021.01.003</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalamakis</surname><given-names>G</given-names></name><name><surname>Brune</surname><given-names>D</given-names></name><name><surname>Ravichandran</surname><given-names>S</given-names></name><name><surname>Bolz</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name><name><surname>Ziebell</surname><given-names>F</given-names></name><name><surname>Stiehl</surname><given-names>T</given-names></name><name><surname>Catala-Martinez</surname><given-names>F</given-names></name><name><surname>Kupke</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>1407</fpage><lpage>1419</lpage><elocation-id>e1414</elocation-id><pub-id pub-id-type="pmid">30827680</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrayeva</surname><given-names>A</given-names></name><name><surname>Bay</surname><given-names>M</given-names></name><name><surname>Pu</surname><given-names>E</given-names></name><name><surname>Jorg</surname><given-names>DJ</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Jun</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Aaron</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Resler</surname><given-names>G</given-names></name><etal/></person-group><article-title>Early stem cell aging in the mature brain</article-title><source>Cell Stem Cell</source><year>2021</year><volume>28</volume><fpage>955</fpage><lpage>966</lpage><elocation-id>e957</elocation-id><pub-id pub-id-type="pmcid">PMC10069280</pub-id><pub-id pub-id-type="pmid">33848469</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2021.03.018</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>J</given-names></name><name><surname>Urban</surname><given-names>N</given-names></name><name><surname>Achimastou</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>A</given-names></name><name><surname>Simic</surname><given-names>M</given-names></name><name><surname>Ullom</surname><given-names>K</given-names></name><name><surname>Martynoga</surname><given-names>B</given-names></name><name><surname>Lebel</surname><given-names>M</given-names></name><name><surname>Goritz</surname><given-names>C</given-names></name><name><surname>Frisen</surname><given-names>J</given-names></name><etal/></person-group><article-title>A transcriptional mechanism integrating inputs from extracellular signals to activate hippocampal stem cells</article-title><source>Neuron</source><year>2014</year><volume>83</volume><fpage>1085</fpage><lpage>1097</lpage><pub-id pub-id-type="pmcid">PMC4157576</pub-id><pub-id pub-id-type="pmid">25189209</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2014.08.004</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>N</given-names></name><name><surname>van den Berg</surname><given-names>DL</given-names></name><name><surname>Forget</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>J</given-names></name><name><surname>Demmers</surname><given-names>JA</given-names></name><name><surname>Hunt</surname><given-names>C</given-names></name><name><surname>Ayrault</surname><given-names>O</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name></person-group><article-title>Return to quiescence of mouse neural stem cells by degradation of a proactivation protein</article-title><source>Science</source><year>2016</year><volume>353</volume><fpage>292</fpage><lpage>295</lpage><pub-id pub-id-type="pmcid">PMC5321528</pub-id><pub-id pub-id-type="pmid">27418510</pub-id><pub-id pub-id-type="doi">10.1126/science.aaf4802</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blomfield</surname><given-names>IM</given-names></name><name><surname>Rocamonde</surname><given-names>B</given-names></name><name><surname>Masdeu</surname><given-names>MDM</given-names></name><name><surname>Mulugeta</surname><given-names>E</given-names></name><name><surname>Vaga</surname><given-names>S</given-names></name><name><surname>van den Berg</surname><given-names>DL</given-names></name><name><surname>Huillard</surname><given-names>E</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name><name><surname>Urban</surname><given-names>N</given-names></name></person-group><article-title>Id4 promotes the elimination of the pro-activation factor Ascl1 to maintain quiescence of adult hippocampal stem cells</article-title><source>Elife</source><year>2019</year><volume>8</volume><pub-id pub-id-type="pmcid">PMC6805120</pub-id><pub-id pub-id-type="pmid">31552825</pub-id><pub-id pub-id-type="doi">10.7554/eLife.48561</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivas</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>CS</given-names></name><name><surname>William</surname><given-names>CM</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name></person-group><article-title>Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus</article-title><source>BMC Dev Biol</source><year>2001</year><volume>1</volume><fpage>4</fpage><pub-id pub-id-type="pmcid">PMC31338</pub-id><pub-id pub-id-type="pmid">11299042</pub-id><pub-id pub-id-type="doi">10.1186/1471-213X-1-4</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Buffo</surname><given-names>A</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name><name><surname>Kuhn</surname><given-names>R</given-names></name><name><surname>Gotz</surname><given-names>M</given-names></name></person-group><article-title>Inducible gene deletion in astroglia and radial glia--a valuable tool for functional and lineage analysis</article-title><source>Glia</source><year>2006</year><volume>54</volume><fpage>21</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">16652340</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>DA</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Jimenez-Cyrus</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Morizet</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Ringeling</surname><given-names>FR</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><etal/></person-group><article-title>A Common Embryonic Origin of Stem Cells Drives Developmental and Adult Neurogenesis</article-title><source>Cell</source><year>2019</year><volume>177</volume><fpage>654</fpage><lpage>668</lpage><elocation-id>e615</elocation-id><pub-id pub-id-type="pmcid">PMC6496946</pub-id><pub-id pub-id-type="pmid">30929900</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2019.02.010</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodge</surname><given-names>RD</given-names></name><name><surname>Kowalczyk</surname><given-names>TD</given-names></name><name><surname>Wolf</surname><given-names>SA</given-names></name><name><surname>Encinas</surname><given-names>JM</given-names></name><name><surname>Rippey</surname><given-names>C</given-names></name><name><surname>Enikolopov</surname><given-names>G</given-names></name><name><surname>Kempermann</surname><given-names>G</given-names></name><name><surname>Hevner</surname><given-names>RF</given-names></name></person-group><article-title>Intermediate progenitors in adult hippocampal neurogenesis: Tbr2 expression and coordinate regulation of neuronal output</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>3707</fpage><lpage>3717</lpage><pub-id pub-id-type="pmcid">PMC6671086</pub-id><pub-id pub-id-type="pmid">18385329</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4280-07.2008</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Encinas</surname><given-names>JM</given-names></name><name><surname>Michurina</surname><given-names>TV</given-names></name><name><surname>Peunova</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Tordo</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>DA</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name><name><surname>Koulakov</surname><given-names>A</given-names></name><name><surname>Enikolopov</surname><given-names>G</given-names></name></person-group><article-title>Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus</article-title><source>Cell Stem Cell</source><year>2011</year><volume>8</volume><fpage>566</fpage><lpage>579</lpage><pub-id pub-id-type="pmcid">PMC3286186</pub-id><pub-id pub-id-type="pmid">21549330</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2011.03.010</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>K</given-names></name><name><surname>Risso</surname><given-names>D</given-names></name><name><surname>Fletcher</surname><given-names>RB</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Ngai</surname><given-names>J</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Purdom</surname><given-names>E</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group><article-title>Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics</article-title><source>BMC Genomics</source><year>2018</year><volume>19</volume><fpage>477</fpage><pub-id pub-id-type="pmcid">PMC6007078</pub-id><pub-id pub-id-type="pmid">29914354</pub-id><pub-id pub-id-type="doi">10.1186/s12864-018-4772-0</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Berg</surname><given-names>DA</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>JY</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Bonaguidi</surname><given-names>MA</given-names></name><name><surname>Enikolopov</surname><given-names>G</given-names></name><name><surname>Nauen</surname><given-names>DW</given-names></name><name><surname>Christian</surname><given-names>KM</given-names></name><name><surname>Ming</surname><given-names>GL</given-names></name><name><surname>Song</surname><given-names>H</given-names></name></person-group><article-title>Single-Cell RNA-Seq with Waterfall Reveals Molecular Cascades underlying Adult Neurogenesis</article-title><source>Cell Stem Cell</source><year>2015</year><volume>17</volume><fpage>360</fpage><lpage>372</lpage><pub-id pub-id-type="pmcid">PMC8638014</pub-id><pub-id pub-id-type="pmid">26299571</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2015.07.013</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabezas-Wallscheid</surname><given-names>N</given-names></name><name><surname>Buettner</surname><given-names>F</given-names></name><name><surname>Sommerkamp</surname><given-names>P</given-names></name><name><surname>Klimmeck</surname><given-names>D</given-names></name><name><surname>Ladel</surname><given-names>L</given-names></name><name><surname>Thalheimer</surname><given-names>FB</given-names></name><name><surname>Pastor-Flores</surname><given-names>D</given-names></name><name><surname>Roma</surname><given-names>LP</given-names></name><name><surname>Renders</surname><given-names>S</given-names></name><name><surname>Zeisberger</surname><given-names>P</given-names></name><etal/></person-group><article-title>Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy</article-title><source>Cell</source><year>2017</year><volume>169</volume><fpage>807</fpage><lpage>823</lpage><elocation-id>e819</elocation-id><pub-id pub-id-type="pmid">28479188</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhimolea</surname><given-names>E</given-names></name><name><surname>de Matos Simoes</surname><given-names>R</given-names></name><name><surname>Kansara</surname><given-names>D</given-names></name><name><surname>Al’Khafaji</surname><given-names>A</given-names></name><name><surname>Bouyssou</surname><given-names>J</given-names></name><name><surname>Weng</surname><given-names>X</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Raja</surname><given-names>J</given-names></name><name><surname>Awate</surname><given-names>P</given-names></name><name><surname>Shirasaki</surname><given-names>R</given-names></name><etal/></person-group><article-title>An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence</article-title><source>Cancer Cell</source><year>2021</year><volume>39</volume><fpage>240</fpage><lpage>256</lpage><elocation-id>e211</elocation-id><pub-id pub-id-type="pmcid">PMC8670073</pub-id><pub-id pub-id-type="pmid">33417832</pub-id><pub-id pub-id-type="doi">10.1016/j.ccell.2020.12.002</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Alboran</surname><given-names>IM</given-names></name><name><surname>O’Hagan</surname><given-names>RC</given-names></name><name><surname>Gartner</surname><given-names>F</given-names></name><name><surname>Malynn</surname><given-names>B</given-names></name><name><surname>Davidson</surname><given-names>L</given-names></name><name><surname>Rickert</surname><given-names>R</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><article-title>Analysis of C-MYC function in normal cells via conditional gene-targeted mutation</article-title><source>Immunity</source><year>2001</year><volume>14</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">11163229</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoepfler</surname><given-names>PS</given-names></name><name><surname>Cheng</surname><given-names>PF</given-names></name><name><surname>Eisenman</surname><given-names>RN</given-names></name></person-group><article-title>N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation</article-title><source>Genes Dev</source><year>2002</year><volume>16</volume><fpage>2699</fpage><lpage>2712</lpage><pub-id pub-id-type="pmcid">PMC187459</pub-id><pub-id pub-id-type="pmid">12381668</pub-id><pub-id pub-id-type="doi">10.1101/gad.1021202</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopecky</surname><given-names>BJ</given-names></name><name><surname>Decook</surname><given-names>R</given-names></name><name><surname>Fritzsch</surname><given-names>B</given-names></name></person-group><article-title>N-Myc and L-Myc are essential for hair cell formation but not maintenance</article-title><source>Brain Res</source><year>2012</year><volume>1484</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmcid">PMC3482343</pub-id><pub-id pub-id-type="pmid">23022312</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2012.09.027</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malynn</surname><given-names>BA</given-names></name><name><surname>de Alboran</surname><given-names>IM</given-names></name><name><surname>O’Hagan</surname><given-names>RC</given-names></name><name><surname>Bronson</surname><given-names>R</given-names></name><name><surname>Davidson</surname><given-names>L</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group><article-title>N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1390</fpage><lpage>1399</lpage><pub-id pub-id-type="pmcid">PMC316670</pub-id><pub-id pub-id-type="pmid">10837031</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux de Bezieux</surname><given-names>H</given-names></name><name><surname>Van den Berge</surname><given-names>K</given-names></name><name><surname>Street</surname><given-names>K</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group><article-title>Trajectory inference across multiple conditions with condiments</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><fpage>833</fpage><pub-id pub-id-type="pmcid">PMC10821945</pub-id><pub-id pub-id-type="pmid">38280860</pub-id><pub-id pub-id-type="doi">10.1038/s41467-024-44823-0</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Berge</surname><given-names>K</given-names></name><name><surname>Roux de Bezieux</surname><given-names>H</given-names></name><name><surname>Street</surname><given-names>K</given-names></name><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name><name><surname>Clement</surname><given-names>L</given-names></name></person-group><article-title>Trajectory-based differential expression analysis for single-cell sequencing data</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>1201</elocation-id><pub-id pub-id-type="pmcid">PMC7058077</pub-id><pub-id pub-id-type="pmid">32139671</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-14766-3</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mira</surname><given-names>H</given-names></name><name><surname>Andreu</surname><given-names>Z</given-names></name><name><surname>Suh</surname><given-names>H</given-names></name><name><surname>Lie</surname><given-names>DC</given-names></name><name><surname>Jessberger</surname><given-names>S</given-names></name><name><surname>Consiglio</surname><given-names>A</given-names></name><name><surname>San Emeterio</surname><given-names>J</given-names></name><name><surname>Hortigüela</surname><given-names>R</given-names></name><name><surname>Marqués-Torrejón</surname><given-names>MA</given-names></name><name><surname>Nakashima</surname><given-names>K</given-names></name><etal/></person-group><article-title>Signaling through BMPR-IA Regulates Quiescence and Long-Term Activity of Neural Stem Cells in the Adult Hippocampus</article-title><source>Cell Stem Cell</source><year>2010</year><volume>7</volume><fpage>78</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">20621052</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imayoshi</surname><given-names>I</given-names></name><name><surname>Sakamoto</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Kageyama</surname><given-names>R</given-names></name></person-group><article-title>Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><fpage>3489</fpage><lpage>3498</lpage><pub-id pub-id-type="pmcid">PMC6634119</pub-id><pub-id pub-id-type="pmid">20203209</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4987-09.2010</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adusumilli</surname><given-names>VS</given-names></name><name><surname>Walker</surname><given-names>TL</given-names></name><name><surname>Overall</surname><given-names>RW</given-names></name><name><surname>Klatt</surname><given-names>GM</given-names></name><name><surname>Zeidan</surname><given-names>SA</given-names></name><name><surname>Zocher</surname><given-names>S</given-names></name><name><surname>Kirova</surname><given-names>DG</given-names></name><name><surname>Ntitsias</surname><given-names>K</given-names></name><name><surname>Fischer</surname><given-names>TJ</given-names></name><name><surname>Sykes</surname><given-names>AM</given-names></name><etal/></person-group><article-title>ROS Dynamics Delineate Functional States of Hippocampal Neural Stem Cells and Link to Their Activity-Dependent Exit from Quiescence</article-title><source>Cell Stem Cell</source><year>2021</year><volume>28</volume><fpage>300</fpage><lpage>314</lpage><elocation-id>e306</elocation-id><pub-id pub-id-type="pmcid">PMC7875116</pub-id><pub-id pub-id-type="pmid">33275875</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2020.10.019</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimaki</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Della Croce</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>HH</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Yao</surname><given-names>G</given-names></name></person-group><article-title>Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch</article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><volume>116</volume><fpage>22624</fpage><lpage>22634</lpage><pub-id pub-id-type="pmcid">PMC6842626</pub-id><pub-id pub-id-type="pmid">31636214</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1915905116</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Dai</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Hua</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>XX</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name></person-group><article-title>c-Myc regulates neural stem cell quiescence and activation by coordinating the cell cycle and mitochondrial remodeling</article-title><source>Signal Transduct Target Ther</source><year>2021</year><volume>6</volume><fpage>306</fpage><pub-id pub-id-type="pmcid">PMC8385022</pub-id><pub-id pub-id-type="pmid">34429397</pub-id><pub-id pub-id-type="doi">10.1038/s41392-021-00664-7</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vue</surname><given-names>TY</given-names></name><name><surname>Kollipara</surname><given-names>RK</given-names></name><name><surname>Borromeo</surname><given-names>MD</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Mashimo</surname><given-names>T</given-names></name><name><surname>Burns</surname><given-names>DK</given-names></name><name><surname>Bachoo</surname><given-names>RM</given-names></name><name><surname>Johnson</surname><given-names>JE</given-names></name></person-group><article-title>ASCL1 regulates neurodevelopmental transcription factors and cell cycle genes in brain tumors of glioma mouse models</article-title><source>Glia</source><year>2020</year><volume>68</volume><fpage>2613</fpage><lpage>2630</lpage><pub-id pub-id-type="pmcid">PMC7587013</pub-id><pub-id pub-id-type="pmid">32573857</pub-id><pub-id pub-id-type="doi">10.1002/glia.23873</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>TK</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kappei</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>SH</given-names></name><name><surname>Look</surname><given-names>AT</given-names></name><name><surname>Sanda</surname><given-names>T</given-names></name></person-group><article-title>ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors</article-title><source>Cell Rep</source><year>2023</year><volume>42</volume><elocation-id>113541</elocation-id><pub-id pub-id-type="pmid">38060444</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>D</surname><given-names>DA</given-names></name><name><surname>Lim</surname><given-names>WK</given-names></name><name><surname>Brahmachary</surname><given-names>M</given-names></name><name><surname>Carro</surname><given-names>MS</given-names></name><name><surname>Ludwig</surname><given-names>T</given-names></name><name><surname>Cardo</surname><given-names>CC</given-names></name><name><surname>Guillemot</surname><given-names>F</given-names></name><name><surname>Aldape</surname><given-names>K</given-names></name><name><surname>Califano</surname><given-names>A</given-names></name><etal/></person-group><article-title>The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain</article-title><source>Dev Cell</source><year>2009</year><volume>17</volume><fpage>210</fpage><lpage>221</lpage><pub-id pub-id-type="pmcid">PMC2769073</pub-id><pub-id pub-id-type="pmid">19686682</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2009.07.009</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martynoga</surname><given-names>B</given-names></name><name><surname>Mateo</surname><given-names>JL</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Andersen</surname><given-names>J</given-names></name><name><surname>Achimastou</surname><given-names>A</given-names></name><name><surname>Urban</surname><given-names>N</given-names></name><name><surname>van den Berg</surname><given-names>D</given-names></name><name><surname>Georgopoulou</surname><given-names>D</given-names></name><name><surname>Hadjur</surname><given-names>S</given-names></name><name><surname>Wittbrodt</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epigenomic enhancer annotation reveals a key role for NFIX in neural stem cell quiescence</article-title><source>Genes Dev</source><year>2013</year><volume>27</volume><fpage>1769</fpage><lpage>1786</lpage><pub-id pub-id-type="pmcid">PMC3759694</pub-id><pub-id pub-id-type="pmid">23964093</pub-id><pub-id pub-id-type="doi">10.1101/gad.216804.113</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mignone</surname><given-names>JL</given-names></name><name><surname>Kukekov</surname><given-names>V</given-names></name><name><surname>Chiang</surname><given-names>AS</given-names></name><name><surname>Steindler</surname><given-names>D</given-names></name><name><surname>Enikolopov</surname><given-names>G</given-names></name></person-group><article-title>Neural stem and progenitor cells in nestin-GFP transgenic mice</article-title><source>J Comp Neurol</source><year>2004</year><volume>469</volume><fpage>311</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">14730584</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>KC</given-names></name><name><surname>Kameda</surname><given-names>H</given-names></name><name><surname>Koshimizu</surname><given-names>Y</given-names></name><name><surname>Yanagawa</surname><given-names>Y</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name></person-group><article-title>Production and histological application of affinity-purified antibodies to heat-denatured green fluorescent protein</article-title><source>J Histochem Cytochem</source><year>2008</year><volume>56</volume><fpage>647</fpage><lpage>657</lpage><pub-id pub-id-type="pmcid">PMC2430162</pub-id><pub-id pub-id-type="pmid">18413647</pub-id><pub-id pub-id-type="doi">10.1369/jhc.2008.950915</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagihara</surname><given-names>H</given-names></name><name><surname>Toyama</surname><given-names>K</given-names></name><name><surname>Yamasaki</surname><given-names>N</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name></person-group><article-title>Dissection of hippocampal dentate gyrus from adult mouse</article-title><source>J Vis Exp</source><year>2009</year><pub-id pub-id-type="pmcid">PMC3142893</pub-id><pub-id pub-id-type="pmid">19920804</pub-id><pub-id pub-id-type="doi">10.3791/1543</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>TL</given-names></name><name><surname>Kempermann</surname><given-names>G</given-names></name></person-group><article-title>One mouse, two cultures: isolation and culture of adult neural stem cells from the two neurogenic zones of individual mice</article-title><source>J Vis Exp</source><year>2014</year><elocation-id>e51225</elocation-id><pub-id pub-id-type="pmcid">PMC4131911</pub-id><pub-id pub-id-type="pmid">24637893</pub-id><pub-id pub-id-type="doi">10.3791/51225</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names><suffix>3rd</suffix></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><article-title>Comprehensive Integration of Single-Cell Data</article-title><source>Cell</source><year>2019</year><volume>777</volume><fpage>1888</fpage><lpage>1902</lpage><elocation-id>e1821</elocation-id><pub-id pub-id-type="pmcid">PMC6687398</pub-id><pub-id pub-id-type="pmid">31178118</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names><suffix>3rd</suffix></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><etal/></person-group><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><elocation-id>e3529</elocation-id><pub-id pub-id-type="pmcid">PMC8238499</pub-id><pub-id pub-id-type="pmid">34062119</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becht</surname><given-names>E</given-names></name><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Dutertre</surname><given-names>CA</given-names></name><name><surname>Kwok</surname><given-names>IWH</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Newell</surname><given-names>EW</given-names></name></person-group><article-title>Dimensionality reduction for visualizing single-cell data using UMAP</article-title><source>Nat Biotechnol</source><year>2018</year><pub-id pub-id-type="pmid">30531897</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhen</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name></person-group><article-title>A mouse tissue transcription factor atlas</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><elocation-id>15089</elocation-id><pub-id pub-id-type="pmcid">PMC5413951</pub-id><pub-id pub-id-type="pmid">28429721</pub-id><pub-id pub-id-type="doi">10.1038/ncomms15089</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><etal/></person-group><article-title>clusterProfiler 4.0: A universal enrichment tool for interpreting omics data</article-title><source>Innovation (Camb)</source><year>2021</year><volume>2</volume><elocation-id>100141</elocation-id><pub-id pub-id-type="pmcid">PMC8454663</pub-id><pub-id pub-id-type="pmid">34557778</pub-id><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title><italic>Ascl1</italic> loss reduces NSC activation by impeding progression from deep states of quiescence.</title><p>(A) To assess how loss of ASCL1 affects quiescence, mouse hippocampal dentate gyrus was dissected, and genetically recombined cells (Glast-creERT2; RosaYFP) lacking <italic>Ascl1</italic> (<italic>Ascl1</italic> cKO) and controls were processed for scRNA-seq.</p><p>(B) UMAP of single cell transcriptomes from <italic>Ascl1</italic> cKO and control mice showing quiescent NSCs, proliferating cells (NSCs and intermediate progenitors) and neuroblasts.</p><p>(C) UMAP of single cell transcriptomes from <italic>Ascl1</italic> cKO and control mice split by genotype.</p><p>(D) Quantification of the proportion of quiescent NSCs, proliferating cells and neuroblasts in <italic>Ascl1</italic> cKO and control mice.</p><p>(E) UMAP of NSCs from <italic>Ascl1</italic> cKO and control mice.</p><p>(F) Pseudotime analysis of quiescent NSCs from <italic>Ascl1</italic> cKO and control mice. Left: Analysis visualised using first two principal components, with cells coloured by pseudotime and cell ordering indicated by black arrow. Right: Distribution of pseudotime values per genotype.</p><p>Statistics: Kolmogorov-Smirnov test in (F), multiple comparison t-test in (D) reporting Holm-Sidak corrected <italic>P</italic>-value. **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001. Abbreviations: intermediate progenitor cell (IPC).</p></caption><graphic xlink:href="EMS199808-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Ascl1 gain-of-function increases NSC activation by promoting progression from deep states of quiescence.</title><p>(A) To assess how loss of HUWE1 affects quiescence, mouse hippocampal dentate gyrus was dissected, and genetically recombined cells (Glast-creERT2; RosaYFP) lacking <italic>Huwe1</italic> (<italic>Huwe1</italic> cKO) and controls were processed for scRNA-seq.</p><p>(B) UMAP of single cell transcriptomes from <italic>Huwe1</italic> cKO and control mice showing quiescent NSCs, proliferating cells (NSCs and intermediate progenitors) and neuroblasts.</p><p>(C) UMAP of single cell transcriptomes from <italic>Huwe1</italic> cKO and control mice coloured by genotype.</p><p>(D) Quantification of the proportion of quiescent NSCs, proliferating cells and neuroblasts in <italic>Huwe1</italic> cKO and control mice.</p><p>(E) UMAP of NSCs from <italic>Huwe1</italic> cKO and control mice.</p><p>(F) Pseudotime analysis of quiescent NSCs from <italic>Huwe1</italic> cKO and control mice. Left: Analysis visualised using first two principal components, with cells coloured by pseudotime and cell ordering indicated by black arrow. Right: Distribution of pseudotime values per genotype.</p><p>Statistics: Kolmogorov-Smirnov test in (F), multiple comparison t-test in (D) reporting Holm-Sidak corrected <italic>P</italic>-value. ***<italic>P</italic> &lt; 0.001. Abbreviations: intermediate progenitor cell (IPC).</p></caption><graphic xlink:href="EMS199808-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title><italic>Mycn</italic> loss reduces NSC activation by impeding progression from shallow states of quiescence.</title><p>(A) To assess how loss of MYCN affects NSC quiescence, mouse hippocampal dentate gyrus was dissected, and Nestin::GFP positive cells from <italic>Mycn</italic> cKO and controls were processed for scRNA-seq.</p><p>(B) UMAP of single cell transcriptomes from <italic>Mycn</italic> cKO and control mice showing quiescent NSCs, proliferating cells (NSCs and intermediate progenitors) and neuroblasts.</p><p>(C) UMAP of single cell transcriptomes from <italic>Mycn</italic> cKO and control split by genotype.</p><p>(D) Quantification of quiescent NSCs, proliferating cells (NSCs and intermediate progenitors) and neuroblasts in <italic>Mycn</italic> cKO and control mice.</p><p>(E) UMAP of NSCs from <italic>Mycn</italic> cKO and control mice. Abbreviations: intermediate progenitor cell (IPC).</p><p>(F) Pseudotime analysis of quiescent NSCs from <italic>Mycn</italic> cKO and control mice. Left: Analysis visualised using first two principal components, with cells coloured by pseudotime and cell ordering indicated by black arrow. Right: Distribution of pseudotime values per genotype.</p><p>Statistics: Kolmogorov-Smirnov test in (F), multiple comparison t-test in (D) reporting Holm-Sidak corrected <italic>P</italic>-value. **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001.</p></caption><graphic xlink:href="EMS199808-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>A sequential <italic>Ascl1-Mycn</italic> program drives NSC activation.</title><p>(A) UMAP showing <italic>Ascl1</italic> and <italic>Mycn</italic> expression in wildtype NSCs. Data from <italic>Ascl1</italic> control mice in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><p>(B) <italic>Ascl1</italic> and <italic>Mycn</italic> expression in wildtype NSCs along pseudotime from deep quiescence to an active state. Data from <italic>Ascl1</italic> control mice in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><p>(C) UMAP plot showing <italic>Mycn</italic> expression in <italic>Ascl1</italic> cKO and control NSCs.</p><p>(D) Scatterplot of <italic>Mycn</italic> expression in <italic>Ascl1</italic> cKO and control NSCs. Batch indicates experiment number.</p><p>(E) MYCN protein is detected in fewer NSCs in <italic>Ascl1</italic> cKO NSCs than in <italic>Ascl1</italic> control NSCs.</p><p>(F) Quantification of the proportion of NSCs that are quiescent and positive for MYCN (MYCN+KI67–) and the proportion that are active and positive for MYCN (MYCN+KI67+) in <italic>Ascl1 cKO</italic> and control mice.</p><p>(G) UMAP plot showing <italic>Mycn</italic> expression in <italic>Huwe1</italic> cKO and control NSCs.</p><p>(H) Scatterplot of <italic>Mycn</italic> expression in <italic>Huwe1</italic> cKO and control NSCs. Batch indicates experiment number.</p><p>(I) ASCL1 ChIP data at <italic>Mycn</italic> locus in adult hippocampus derived NSCs. Dataset from Andersen et al., 2014<sup><xref ref-type="bibr" rid="R9">9</xref></sup> and Martynoga et al., 2013<sup><xref ref-type="bibr" rid="R35">35</xref></sup>.</p><p>Statistics: Pseudobulk differential expression in (D, H) reporting FDR-corrected <italic>P</italic> value; t test in (F). *<italic>P</italic> &lt; 0.05, ***<italic>P</italic> &lt; 0.001. Scale bar (in E) = 30 μm.</p></caption><graphic xlink:href="EMS199808-f004"/></fig></floats-group></article>